NCT03253211View on ClinicalTrials.gov

Disseminating NIH Evidence Based Sickle Cell Recommendations in North Carolina

CompletedOBSERVATIONAL

Enrollment

4,392

Participants

Timeline

Start Date

November 6, 2018

Primary Completion Date

December 15, 2019

Study Completion Date

December 15, 2019

Conditions

Sickle Cell Disease

Trial Locations (1)

27607

Community Care of North Carolina, Raleigh

Sponsors

Lead Sponsor

Duke University

All Listed Sponsors

collaborator

Agency for Healthcare Research and Quality (AHRQ)

FED

lead

Duke University

OTHER

NCT03253211 - Disseminating NIH Evidence Based Sickle Cell Recommendations in North Carolina | Biotech Hunter | Biotech Hunter